Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study

Fig. 3

Sensitivity analysis of PCSK9 on coronary heart disease and autoimmune diseases. Leave-one-out analysis of PCSK9 on A CHD, B SLE, C MG, D RA, E MS, F asthma, G CD, H UC, and I T1D. The leave-one-out method is used to evaluate the excessive impact of a single SNP on MR analysis if the comprehensive effect of the remaining SNPs is consistent with the main effect after removing one SNP. SNP, single nucleotide polymorphisms; PCSK9, proprotein convertase subtilisin/kexin type 9; CHD, coronary heart disease; SLE, systemic lupus erythematosus; RA, rheumatoid arthritis; MG, myasthenia gravis; MS, multiple sclerosis; CD, Crohn’s disease; UC, ulcerative colitis; T1D, type 1 diabetes

Back to article page